Document:

Exhibit 10.8

 

EMPLOYMENT AGREEMENT

 

AGREEMENT dated as of May 27, 2015 between
Thomas Panza, residing at _____________ (“Employee”), and Long Island Brand Beverages LLC, a New York limited liability
company having its principal office at 116 Charlotte Avenue, Hicksville, NY 11801 (“Company”);

 

WHEREAS, the Company has entered into an
Agreement and Plan of Reorganization (the “Merger Agreement”), dated dated as of December 31, 2014 and amended as of
April 23, 2015, by and among the Company, Cullen Agricultural Holding Corp. (“Cullen Ag”), Long Island Iced Tea Corp.
(“Holdco”), Cullen Merger Sub, Inc., LIBB Acquisition Sub, LLC and the founders of LIBB;

 

WHEREAS, the Company desires to enter into
a new employment agreement with Employee to take effect upon consummation of the transactions contemplated by the Merger Agreement
(the “Commencement Date”); and

 

WHEREAS, Employee is willing to enter into
such employment agreement on the terms, conditions and provisions hereinafter set forth.

 

NOW, THEREFORE, in consideration of the
mutual promises, terms, covenants and conditions set forth herein and the performance of each, the parties hereby agree as follows:

 

 

 

IT IS AGREED:

 

1.           Employment,
Duties and Acceptance.

 

1.1           General.
During the Term (as defined in Section 2), the Company shall employ Employee in the position of Purchasing Manager of the Company
and such other positions as shall be given to Employee by the Chief Executive Officer (CEO). All of Employee’s powers and
authority in any capacity shall at all times be subject to the direction and control of the Company’s Chief Executive Officer.
The CEO may assign to Employee such management and supervisory responsibilities and duties for the Company or any subsidiary of
the Company, as are consistent with Employee’s status as Purchasing Manager. The Company and Employee acknowledge that Employee’s
primary functions and duties as Purchasing Manager shall be to assist the Company in managing all hands-on operational aspects
of the company with a primary focus on management of the Company’s inventory control and oversight
of supply chain management and procurement.
Purchasing manager will be responsible for buying the best quality equipment, goods
and services for the Company or organization at the most competitive prices.

 

    	1

    	 

    

 

1.2           Full-Time
Position. Employee accepts such employment and agrees to devote substantially all of his business time, energies and attention
to the performance of his duties hereunder. Nothing herein shall be construed as preventing Employee from making and supervising
personal investments, provided they will not interfere with the performance of Employee’s duties hereunder or violate the
provisions of Section 5.4 hereof.

 

1.3           Location.
Employee will perform his duties in or around Hicksville, New York. Employee shall undertake such occasional travel, within or
outside the United States, as is reasonably necessary in the interests of the Company.

 

2.           Term.
The term of Employee’s employment hereunder shall commence on the Commencement Date and shall continue until the second anniversary
of the Commencement Date (“Term”) unless terminated earlier as hereinafter provided in this Agreement, or unless extended
by mutual written agreement of the Company and Employee. This Agreement shall become null and void in the event of the termination
of the Merger Agreement prior to the consummation of the transactions contemplated thereby. Notwithstanding any provision in this
Agreement to the contrary, this Agreement shall become effective only upon consummation of the transactions contemplated by the
Merger Agreement. Unless the Company and Employee have otherwise agreed in writing, if Employee continues to work for the Company
after the expiration of the Term, his employment thereafter shall be under the same terms and conditions provided for in this Agreement,
except that his employment will be on an “at will” basis and the provisions of Sections 4.4 and 4.6(c) shall no longer
be in effect.

 

3.           Compensation
and Benefits.

 

3.1           Salary.
The Company shall pay to Employee a salary (“Base Salary”) at the annual rate of $80,000. Employee’s compensation
shall be paid in equal, periodic installments in accordance with the Company’s normal payroll procedures.

 

    	2

    	 

    

 

3.2           Incentives.
For the period from the Commencement Date until December 31st, 2015, the Employee shall be paid a bonus (“Bonus”)
of up to 50% of the Base Salary. The incentive paid (if any) will be determined by the Chief Executive Officer and the Board at
their discretion. The Bonus will be paid in cash or stock as per the recommendation of the Board.

 

3.3           Benefits.
Employee shall be entitled to such medical, life, disability and other benefits as are generally afforded to other Employees of
the Company, subject to applicable waiting periods and other conditions, as well as participation in all other company-wide employee
benefits, including a defined contribution pension plan and 401(k) plan, as may be made available generally to Employee employees
from time to time. If the benefits in this Section 3.3 are not implemented by the date being six (6) months from the Commencement
Date the Employee will accept by way of substitution the sum of $500.00 per month for the period until the benefits are made available
to the Employee.

 

3.4           Vacation
and Sick Days. Employee shall be entitled to twenty (20) days of paid vacation and five (5) days of paid sick days in each
year during the Term and to a reasonable number of other days off for religious and personal reasons in accordance with customary
Company policy.

 

3.5           Expenses.
The Company shall pay or reimburse Employee for all transportation, hotel and other expenses reasonably incurred by Employee on
business trips and for all other ordinary and reasonable out-of-pocket expenses actually incurred by him in the conduct of the
business of the Company against itemized vouchers submitted with respect to any such expenses and approved in accordance with customary
procedures.

 

3.6           Stock
Options. Subject to approval by the Board of Directors of Holdco, Holdco shall grant Employee an option (“Option”)
to purchase 40,000 shares of Holdco’s Common Stock under Holdco’s 2015 Long-Term Incentive Equity Plan, such Option
to vest quarterly in equal portions over the Term and have an exercise price equal of $3.75. The duration of the Option is for
a five year period ending on the fifth anniversary of the Commencement Date.

 

    	3

    	 

    

 

4.           Termination.

 

4.1           Death.
If Employee dies during the Term, Employee’s employment hereunder shall terminate and the Company shall pay to Employee’s
estate the amount set forth in Section 4.6(a).

 

4.2           Disability.
The Company, by written notice to Employee, may terminate Employee’s employment hereunder if Employee shall fail because
of illness or incapacity to render services of the character contemplated by this Agreement for six (6) consecutive months. Upon
such termination, the Company shall pay to Employee the amount set forth in Section 4.6(a).

 

4.3           By
Company for “Cause”. The Company, by written notice to Employee, may terminate Employee’s employment hereunder
for “Cause”. As used herein, “Cause” shall mean: (a) the refusal or failure by Employee to carry out specific
directions of the Chief Employee Officer or Board which are of a material nature and consistent with his status as Purchasing Manager
(or whichever positions Employee holds at such time), or the refusal or failure by Employee to perform a material part of Employee’s
duties hereunder; (b) the commission by Employee of a material breach of any of the provisions of this Agreement; (c) fraud or
dishonest action by Employee in his relations with the Company or any of its subsidiaries or affiliates (“dishonest”
for these purposes shall mean Employee’s knowingly or recklessly making of a material misstatement or omission for his personal
benefit); or (d) the conviction of Employee of a felony under federal or state law. Notwithstanding the foregoing, no “Cause”
for termination shall be deemed to exist with respect to Employee’s acts described in clauses (a) or (b) above, unless the
Company shall have given written notice to Employee within a period not to exceed ten (10) calendar days of the initial existence
of the occurrence, specifying the “Cause” with reasonable particularity and, within thirty (30) calendar days after
such notice, Employee shall not have cured or eliminated the problem or thing giving rise to such “Cause;” provided,
however, no more than two cure periods need be provided during any twelve-month period. Upon such termination, the Company shall
pay to Employee the amount set forth in Section 4.6(b).

 

    	4

    	 

    

 

4.4           By
Employee for “Good Reason”. The Employee, by written notice to the Company, may terminate Employee’s employment
hereunder if a “Good Reason” exists. For purposes of this Agreement, “Good Reason” shall mean the occurrence
of any of the following circumstances without the Employee’s prior written consent: (a) a substantial and material adverse
change in the nature of Employee’s title, duties and/or responsibilities with the Company that represents a demotion from
his title, duties or responsibilities as in effect immediately prior to such change (such change, a “Demotion”); (b)
material breach of this Agreement by the Company; (c) a failure by the Company to make any payment to Employee when due, unless
the payment is not material and is being contested by the Company, in good faith; or (d) a liquidation, bankruptcy or receivership
of the Company. Notwithstanding the foregoing, no “Good Reason” shall be deemed to exist with respect to the Company’s
acts described in clauses (a), (b) or (c) above, unless Employee shall have given written notice to the Company within a period
not to exceed ten (10) calendar days of the Employee’s knowledge of the initial existence of the occurrence, specifying the
“Good Reason” with reasonable particularity and, within thirty (30) calendar days after such notice, the Company shall
not have cured or eliminated the problem or thing giving rise to such “Good Reason”; provided, however, that no more
than two cure periods shall be provided during any twelve-month period of a breach of clauses (a), (b) or (c) above. Upon such
termination, the Company shall pay to Employee the amount set forth in Section 4.6(c).

 

4.5           Without
“Cause”. Either the Company or the Employee may terminate Employee’s employment hereunder without “Cause”
by giving at least six (6) months written notice to the other party. Upon such termination, the Company shall pay to Employee the
amount set forth in Section 4.6(c).

 

4.6           Compensation
Upon Termination. In the event that Employee’s employment hereunder is terminated, the Company shall pay to Employee
the following compensation:

 

(a)           Payment
Upon Death or Disability. In the event that Employee’s employment is terminated pursuant to Sections 4.1 or 4.2, the
Company shall no longer be under any obligation to Employee or his legal representatives pursuant to this Agreement except for:
(i) the Base Salary due Employee pursuant to Section 3.1 hereof through the date of termination; (ii) all valid expense reimbursements;
(iii) all accrued but unused vacation pay; and (iv) all earned and previously approved but unpaid Bonuses for any year prior to
the year of termination.

 

    	5

    	 

    

 

(b)           Payment
Upon Termination by the Company For “Cause”. In the event that the Company terminates Employee’s employment
hereunder pursuant to Section 4.3, the Company shall have no further obligations to the Employee hereunder, except for: (i) the
Base Salary due Employee pursuant to Section 3.1 hereof through the date of termination; (ii) all valid expense reimbursements;
and (iii) all unused vacation pay through the date of termination required by law to be paid.

 

(c)           Payment
Upon Termination Without Cause or by Employee for Good Reason. In the event that Employee’s employment is terminated
pursuant to Sections 4.4 or 4.5, the Company shall have no further obligations to Employee hereunder except for: (i) six (6) months
of Base Salary due Employee pursuant to Section 3.1, which shall be paid in accordance with the Company’s normal payroll
procedures unless otherwise mutually agreed to by the Employee and the Company; (ii) all valid expense reimbursements; and (iii)
all accrued but unused vacation pay (pro rata for the period to the date of termination).

 

(d)           Employee
shall have no duty to mitigate awards paid or payable to him pursuant to this Agreement, and any compensation paid or payable to
Employee from sources other than the Company will not offset or terminate the Company’s obligation to pay to Employee the
full amounts pursuant to this Agreement.

 

5.           Protection
of Confidential Information; Non-Competition.

 

5.1           Acknowledgment.
Employee acknowledges that:

 

(a)           As
a result of his employment with the Company, Employee has obtained and will obtain secret and confidential information concerning
the business of the Company and its subsidiaries (referred to collectively in this Section 5 as the “Company”), including,
without limitation, financial information, proprietary rights, trade secrets and “know-how,” customers and sources
(“Confidential Information”).

 

(b)           The
Company will suffer substantial damage which will be difficult to compute if, during the period of his employment with the Company
or thereafter, Employee should enter a business competitive with the Company or divulge Confidential Information.

 

    	6

    	 

    

 

(c)           The
provisions of this Agreement are reasonable and necessary for the protection of the business of the Company.

 

5.2           Confidentiality.
Employee agrees that he will not at any time, during the Term or thereafter, divulge to any person or entity any Confidential Information
obtained or learned by him as a result of his employment with the Company, except (i) in the course of performing his duties hereunder,
(ii) with the Company’s prior written consent; (iii) to the extent that any such information is in the public domain other
than as a result of Employee’s breach of any of his obligations hereunder; or (iv) where required to be disclosed by court
order, subpoena or other government process. If Employee shall be required to make disclosure pursuant to the provisions of clause
(iv) of the preceding sentence, Employee promptly, but in no event more than 48 hours after learning of such subpoena, court order,
or other government process, shall notify, confirmed by mail, the Company and, at the Company’s expense, Employee shall:
(a) take all reasonably necessary and lawful steps required by the Company to defend against the enforcement of such subpoena,
court order or other government process, and (b) permit the Company to intervene and participate with counsel of its choice in
any proceeding relating to the enforcement thereof.

 

5.3           Documents.
Upon termination of his employment with the Company, Employee will promptly deliver to the Company all memoranda, notes, records,
reports, manuals, drawings, blueprints and other documents (and all copies thereof) relating to the business of the Company and
all property associated therewith, which he may then possess or have under his control; provided, however, that Employee shall
be entitled to retain copies of such documents reasonably necessary to document his financial relationship with the Company.

 

5.4           Non-Competition.
For and in consideration of the transactions contemplated by the Merger Agreement and the consideration the Employee will receive
as a result thereby, Employee hereby agrees as follows:

 

(a)           Employee
shall not during the period of his employment by or with the Company and for the Applicable Period (defined below), for himself
or on behalf of, or in conjunction with, any other person, persons, company, partnership, limited liability company, corporation
or business of whatever nature:

 

    	7

    	 

    

 

(i)           engage,
as an officer, director, manager, member, shareholder, owner, partner, joint venturer, trustee, or in a managerial capacity, whether
as an employee, independent contractor, agent, consultant or advisor, or as a sales representative, in an entity that designs,
researches, develops, markets, sells or licenses products or services that are substantially similar to or competitive with the
business of the Company that is located within seventy-five (75) miles of any market in which Company currently operates or has
plans to do business in at the time of termination;

 

(ii)           call
upon any person who is at that time, or within the preceding twenty-four (24) months has been, an employee of the Company, for
the purpose, or with the intent, of enticing such employee away from, or out of, the employ of the Company or for the purpose of
hiring such person for Employee or any other person or entity, unless any such person was terminated by the Company more than six
(6) months prior thereto;

 

(iii)           call
upon any person who, or entity that is then or that has been within one year prior to that time, a customer of the Company, for
the purpose of soliciting or selling products or services in competition with the Company; or

 

(iv)           call
upon any prospective acquisition or investment candidate, on the Employee’s own behalf or on behalf of any other person or
entity, which candidate was known by Employee to have, within the previous twenty-four (24) months, been called upon by the Company
or for which the Company made an acquisition or investment analysis or contemplated a joint marketing or joint venture arrangement
with, for the purpose of acquiring or investing or enticing such entity into a joint marketing or joint venture arrangement.

 

 

For purposes of this Section 5:

 

		·	the term “Company” shall be deemed to include the Holdco, Company and any of its respective subsidiaries; and

 

		·	the term “Applicable Period” shall mean two (2) years from the consummation of the Merger Agreement.

 

5.5           Injunctive
Relief. If Employee commits a breach, or threatens to commit a breach, of any of the provisions of Section 5.2 or 5.4, the
Company shall have the right and remedy to seek to have the provisions of this Agreement specifically enforced by any court having
equity jurisdiction, it being acknowledged and agreed by Employee that the services being rendered hereunder to the Company are
of a special, unique and extraordinary character and that any such breach or threatened breach will cause irreparable injury to
the Company and that money damages will not provide an adequate remedy to the Company. The rights and remedies enumerated in this
Section 5.5 shall be in addition to, and not in lieu of, any other rights and remedies available to the Company under law or equity.
In connection with any legal action or proceeding arising out of or relating to this Agreement, the prevailing party in such action
or proceeding shall be entitled to be reimbursed by the other party for the reasonable attorneys’ fees and costs incurred
by the prevailing party.

 

    	8

    	 

    

 

5.6           Modification.
If any provision of Section 5.2 or 5.4 is held to be unenforceable because of the scope, duration or area of its applicability,
the tribunal making such determination shall have the power to modify such scope, duration, or area, or all of them, and such provision
or provisions shall then be applicable in such modified form.

 

5.7           Survival.
The provisions of this Section 5 shall survive the termination of this Agreement for any reason.

 

6.           Miscellaneous
Provisions.

 

6.1           Notices.
All notices provided for in this Agreement shall be in writing, and shall be deemed to have been duly given when (i) delivered
personally to the party to receive the same, or (ii) when mailed first class postage prepaid, by certified mail, return receipt
requested, addressed to the party to receive the same at his or its address set forth below, or such other address as the party
to receive the same shall have specified by written notice given in the manner provided for in this Section 6.1. All notices shall
be deemed to have been given as of the date of personal delivery or mailing thereof.

 

 

If to Employee:

 

Thomas Panza

 

If to the Company:

 

Long Island Brand Beverages LLC

116 Charlotte Avenue

Hicksville, New York 11801

                       

 

    	9

    	 

    

 

6.2           Entire
Agreement; Waiver. This Agreement sets forth the entire agreement of the parties relating to the employment of Employee and
is intended to supersede all prior negotiations, understandings and agreements. No provisions of this Agreement may be waived or
changed except by a writing by the party against whom such waiver or change is sought to be enforced. The failure of any party
to require performance of any provision hereof or thereof shall in no manner affect the right at a later time to enforce such provision.

 

6.3           Governing
Law. All questions with respect to the construction of this Agreement, and the rights and obligations of the parties hereunder,
shall be determined in accordance with the law of the State of New York applicable to agreements made and to be performed entirely
in New York.

 

6.4           Binding
Effect; Nonassignability. This Agreement shall inure to the benefit of and be binding upon the successors and assigns of the
Company. This Agreement shall not be assignable by Employee, but shall inure to the benefit of and be binding upon Employee’s
heirs and legal representatives.

 

6.5           Severability.
Should any provision of this Agreement become legally unenforceable, no other provision of this Agreement shall be affected, and
this Agreement shall continue as if the Agreement had been executed absent the unenforceable provision.

 

6.6           Section
409A. This Agreement is intended to comply with the provisions of Section 409A of the Internal Revenue Code (“Section
409A”). To the extent that any payments and/or benefits provided hereunder are not considered compliant with Section 409A,
the parties agree that the Company shall take all actions necessary to make such payments and/or benefits become compliant.

 

    	10

    	 

    

 

IN WITNESS WHEREOF, the parties have executed
this Agreement on the date first above written.

 

	 	LONG ISLAND BRAND BEVERAGES LLC
	 	 
	 	 
	 	/s/ Philip Thomas
	 	By: Philip Thomas
	 	 
	 	 
	 	 
	 	/s/ Thomas Panza
	 	THOMAS PANZA
	 	 

 

 

 

 

    	11EX-10.13

 Exhibit 10.13 

***Text Omitted and Filed Separately 

with the Securities and Exchange Commission. 

Confidential Treatment Requested 

Under 17 C.F.R. Sections 200.80(b)(4) 

and 230.406 
 SERVICES
AGREEMENT 
 THIS SERVICES AGREEMENT (this “Agreement”),
effective as of October 1, 2014 (the “Effective Date”), is by and between, WELLSPRING BIOSCIENCES LLC, a Delaware limited liability corporation (“Wellspring”),
and KURA ONCOLOGY, INC., a Delaware corporation (the “Company”). 

WHEREAS, the Company desires to engage Wellspring to provide the Company various services and make
available to the Company certain resources of Wellspring on the terms set forth herein. 
 NOW,
THEREFORE, in consideration of the above promises and for other good and valid consideration, the receipt and adequacy of which are hereby acknowledged, the parties, intending to be legally bound, agree as follows:

 ARTICLE 1 

DEFINED TERMS 

1.1 “Company Confidential Information” shall mean (a) the Company Work Product and (b) any and all other data,
information, technology, samples and specimens of the Company or its products, product concepts, technologies, businesses, financial, marketing, clinical or regulatory affairs, manufacturing processes and procedures, or those of any other third
party, whether written, graphic or oral, and whether or not furnished to or obtained by Wellspring, either directly or indirectly, during the course of performing Services hereunder; but excluding, in any event, the Methodology Information and
Wellspring Work Product. Wellspring shall be considered the receiving party with respect to all Company Confidential Information. 

1.2 “Company Intellectual Property” shall have the meaning provided in Section 2.5(a). 

1.3 “Company Work Product” shall mean any and all results (including data) and products (interim and/or final) of the
Services performed by Wellspring or its subcontractors, consultants or agents, whether tangible or intangible, including, without limitation, each and every invention (whether or not patentable), discovery, design, drawing, protocol, process,
technique, formula, trade secret, device, compound, substance, material, pharmaceutical, method, software program (including without limitation, object code, source code, flow charts, algorithms and related documentation), listing, routine, manual
and specification, whether or not patentable or copyrightable, that are made, developed, perfected, designed, conceived or first reduced to practice by Wellspring (or its subcontractors, consultants or agents), either solely or jointly with others,
in the course of the Services. Notwithstanding the foregoing, Company Work Product shall specifically exclude Methodology Information. 

  
 1 

 1.4 “Confidential Information” shall mean the Wellspring Confidential
Information or the Company’s Confidential Information, as applicable. 
 1.5 “FTE” means the equivalent of
[...***...] over a twelve (12) month period [...***...], which equal [...***...] per year on or directly related to R&D Services. 

1.6 “FTE Costs” means the amount obtained by multiplying (a) the number of FTEs actually expended by or on behalf of
Wellspring for a given period of time by (b) four hundred thousand U.S. dollars (U.S.$400,000). 
 1.7 “Materials”
shall mean any chemical or biological materials provided by the Company to Wellspring for use in the Services or procured by Wellspring specifically for use in the Services. For clarity, in the event a sequence or structure is provided in lieu
of physical quantities, the term “Materials” will be deemed to include such sequences or structures and the physical material derived therefrom. 

1.8 “Methodology Information” shall mean any methods or processes used or developed by or for Wellspring in or for the
provision of Services, or in any documentation, records, raw data, materials (other than Materials), specimens, work product, concepts, information, inventions, improvements, designs, programs, formulas, know-how, or writings related thereto, except
those methods and/or processes, if any, disclosed or provided by the Company to Wellspring as specified in writing and agreed to by Wellspring. 

1.9 “Services” shall have the meaning provided in Section 2.1. 

1.10 “Term” shall have the meaning provided in Section 2.6. 

1.11 “Wellspring Confidential Information” shall mean (a) the Wellspring Work Product and (b) all data,
information, technology, samples and specimens of Wellspring or any other person or entity with which Wellspring has a commercial relationship (other than the Company) or their respective products, technologies, businesses, financial, marketing,
clinical or regulatory affairs, manufacturing processes and procedures, or those of any other third party from whom Wellspring receives information on a confidential basis, whether written, graphic or oral, furnished to or obtained by the Company,
either directly or indirectly, during the course of receiving Services hereunder, including, without limitation, Methodology Information, but excluding the Company’s Work Product. The Company shall be considered the receiving party with respect
to all Wellspring Confidential Information. 
 1.12 “Wellspring Intellectual Property” shall have the meaning
provided in Section 2.5(a). 
 1.13 “Wellspring Key Team” shall mean the individuals as may be agreed to
between Wellspring and the Company from time to time. 
 1.14 “Wellspring Work Product” shall mean any and all
results (including data) and products (interim and/or final) of any activities or services performed by Wellspring on behalf of 

  

					
			2		***Confidential Treatment Requested

 
itself or any third party, other than in the course of performing the Services, whether tangible or intangible, including, without limitation, each and every invention (whether or not
patentable), discovery, design, drawing, protocol, process, technique, formula, trade secret, device, compound, substance, material, pharmaceutical, method, software program (including without limitation, object code, source code, flow charts,
algorithms and related documentation), listing, routine, manual and specification, whether or not patentable or copyrightable, and that are made, developed, perfected, designed, conceived or first reduced to practice by Wellspring, either solely or
jointly with others, whether before, during or after the Term, including, without limitation, the Methodology Information. 

ARTICLE 2 

SERVICES 

2.1 Services. Subject to the terms of this Agreement, for the Term determined pursuant to Section 2.6(a) hereof, Wellspring shall
provide or cause to be provided to the Company such services, in the nature of those described on Exhibit A, as may reasonably be requested by the Company and reasonably approved by Wellspring from time to time following the date hereof (the
“Services”). 
 2.2 Charges and Payment. As compensation for its services hereunder, Wellspring shall be
entitled to receive from the Company, and the Company is obligated to pay fees to Wellspring, for the provision of the Services. The Company shall pay Wellspring for the Services in accordance with the provisions of Exhibit B attached
hereto. 
 2.3 General Obligations; Standard of Care. 

(a) Performance Requirements. Wellspring shall use commercially reasonable efforts to provide Services subject to the terms of this
Agreement and in accordance with its policies, procedures and practices then in effect, and shall exercise substantially the same care and skill as it exercises in performing similar activities to the services for itself. 

(b) Changes. The parties acknowledge that Wellspring may make changes from time to time in the manner of performing the Services. Such
changes shall be made in consultation with the Company. 
 (c) Compliance. Wellspring agrees to perform the Services in accordance
with the terms and conditions contained in this Agreement and in compliance with all applicable federal, state and local laws and regulations, including without limitation, the U.S. Foreign Corrupt Practices Act (15 U.S.C. Section 78dd-1, et.
seq.) as amended (“FCPA”). In furtherance of the foregoing, Wellspring shall conduct its activities hereunder in accordance with the guidelines set forth in Exhibit C (Compliance with Laws and the FCPA). 

(d) Communication. On a regular basis during the Term, the parties shall conduct meetings, either in person or by telephone or video
conference, to discuss the progress and results of the Services. 
 (e) Services by Wellspring Key Team. It is the present intention
of 

  
 3 

 
Wellspring that substantially all of the Services will be provided and/or overseen by members of the Wellspring Key Team, as agreed from time to time. 

(f) Subcontracting. Wellspring may subcontract Services to third parties provided that Wellspring will ensure that it enters into an
agreement with each subcontractor that, at a minimum, provides for ownership and allocation of intellectual property rights and for obligations of confidentiality of information, that are consistent with the intent and terms of this Agreement.
Wellspring will remain liable to Company for the performance of any of its obligations hereunder that it delegates to a subcontractor. 

2.4 Confidentiality. 

(a) Confidentiality. Except to the extent expressly authorized by this Agreement or otherwise agreed in writing by the parties, the
parties agree that, during the Term of this Agreement and thereafter, the receiving party shall keep confidential and shall not publish or otherwise disclose and shall not use for any purpose other than as expressly provided for in this Agreement
any Confidential Information of the other party. Each party may use the other party’s Confidential Information only to the extent required to accomplish the purposes of this Agreement, consistent with any restrictions on the use of Confidential
Information received from a third party and communicated by the party disclosing such Confidential Information (“Third Party Restrictions”). To the extent that any Third Party Restrictions exceed the restrictions on the use
of Confidential Information set forth in this Agreement, the parties each hereby agree to be bound by such Third Party Restrictions. The parties agree and acknowledge that certain Confidential Information may be required for submission to the U.S.
Food and Drug Administration and/or federal or state regulatory bodies. The parties acknowledge and agree that such submissions, to the extent required by applicable law, shall not constitute a violation of the terms of this Agreement if permitted
under any applicable agreement with a third party from whom the disclosing party obtained the Confidential Information. Each party will use at least the same standard of care as it uses to protect proprietary or confidential information of its own
(but in no event less than reasonable care) to ensure that its employees, agents, consultants and other representatives do not disclose or make any unauthorized use of such Confidential Information. Each party will promptly notify the other upon
discovery of any unauthorized use or disclosure of such Confidential Information. 
 (b) Limitations. Confidential Information shall
not include any information that the receiving party can prove by competent evidence: (i) was already known to the receiving party without any obligations of confidentiality prior to receipt from the other party; (ii) was generally
available to the public or otherwise part of the public domain at the time of its disclosure to the receiving party; (iii) became generally available to the public or otherwise part of the public domain after its disclosure, other than through
any act or omission of the receiving party in breach of any obligation of confidentiality; (iv) was disclosed to the receiving party, other than under an obligation of confidentiality, by a third party who had no obligation not to disclose such
information to others; or (v) was independently discovered or developed by the receiving party without the use of Confidential Information; provided, however, that any combination of features or disclosures shall not be deemed to
fall within the foregoing exclusions solely because certain individual features are published or available to the general public or in 

  
 4 

 
the rightful possession of a party unless the combination as a whole falls within any of the above exceptions. 

(c) Authorized Disclosure. Notwithstanding Section 2.4(a), a party may disclose Confidential Information of the other party,
without violating the obligations of this Agreement, to the extent the disclosure is required by a valid order of a court or other governmental body having jurisdiction, provided that such party gives reasonable prior written notice to the other
party of such required disclosure and makes a reasonable effort to obtain, or to assist the other party in obtaining, a protective order preventing or limiting the disclosure and/or requiring that the Confidential Information so disclosed be used
only for the purposes for which the law or regulation requires, or for which the order was issued. 
 (d) Use of Name/Publicity.
Neither party shall use the other party’s name in connection with any publication or promotion without the other party’s written consent, except as required by federal, state or local laws, rules and regulations. Neither party shall
disclose the specific content or terms of this Agreement without the prior written consent of the other party. 
 2.5 Intellectual
Property Rights 
 (a) Ownership. The Company shall own all right, title and interest in and to all Materials and Company Work
Product, including, without limitation, all patent, copyright or other intellectual property rights therein, that is conceived or first reduced to practice by Wellspring (or its subcontractors, consultants or agents), either solely or jointly with
others, in the course of performing the Services (collectively, the “Company Intellectual Property”), and neither this Agreement, nor the provision of the Services hereunder, shall give Wellspring any right, title or interest
in or to any Company Intellectual Property except as provided in the following sentence. The Company hereby grants to Wellspring a non-exclusive, worldwide, fully-paid, royalty-free license, without the right to sublicense, under the Company
Intellectual Property solely as necessary or appropriate to perform Services under this Agreement during the Term. Wellspring shall retain all right, title and interest in and to any and all Methodology Information and Wellspring Work Product,
including, without limitation, all patent, copyright or other intellectual property rights therein (collectively, the “Wellspring Intellectual Property”), and neither this Agreement, nor the provision of the Services
hereunder, shall give the Company any right, title or interest in or to any Wellspring Intellectual Property except as provided in the following sentence. In the event that in the performance of the Services, Wellspring utilizes Wellspring
Intellectual Property, Wellspring hereby grants to the Company a non-exclusive, worldwide, fully-paid, royalty-free license, without the right to sublicense, under such Wellspring Intellectual Property solely as necessary for the Company or its
affiliates or licensees (other than Wellspring) to develop, make, have made, use, sell, offer to sell and import products. 
 (b)
Assignment; Assistance. Wellspring hereby assigns all of Wellspring’s right, title and interest in and to any Company Intellectual Property to the Company without royalty or any other consideration and agrees to execute all applications,
assignments or other instruments reasonably requested by the Company in order for the Company to establish its ownership of such Company Intellectual Property and to obtain whatever protection for such Company Intellectual Property, including
copyright and patent rights in any and all countries designated by the Company on such Company Intellectual Property as the Company shall 

  
 5 

 
determine. Wellspring agrees to assist the Company, or its designee, in every reasonable way (but at the Company’s expense) to secure the Company’s rights in Company Intellectual
Property and any copyrights, patents or other intellectual property rights relating to all Company Intellectual Property in any and all countries designated by the Company, including the disclosure to the Company of all pertinent information and
data with respect to all Company Intellectual Property, the execution of all applications, specifications, oaths, assignments and all other instruments that the Company may deem necessary in order to apply for and obtain such rights and in order to
assign and convey to the Company, its successors, assigns and nominees the sole and exclusive right, title and interest in and to all Company Intellectual Property. Wellspring also agrees that its obligation to execute or cause to be executed any
such instrument or papers shall continue after the expiration or termination of this Agreement. Wellspring agrees that, if the Company is unable because of Wellspring’s unavailability, dissolution, or otherwise, to secure Wellspring’s
signature for the purpose of applying for or pursuing any application for any United States or foreign patents or copyright registrations covering the Company Intellectual Property assigned to the Company herein, then, until such time Wellspring
becomes available it hereby designates and appoints the Company and its duly authorized officers and agents as Wellspring’s agent and attorney-in-fact, to act for and on Wellspring’s behalf to execute and file any such applications and to
do all other lawfully permitted acts only to further the prosecution and issuance of patents and copyright registrations with the same legal force and effect as if executed by Wellspring. 

2.6 Term; Termination. 

(a) Term. This Agreement shall be in effect from the Effective Date until December 31, 2015 (the “Initial
Term”) and shall be renewed automatically thereafter for additional consecutive periods of one (1) year each (each a “Renewal Term”) unless either party gives notice to the other party of its intention to
terminate at least thirty (30) days prior to the expiration of the Initial Term or then-current Renewal Term, as applicable (the Initial Term and all Renewal Terms, collectively, the “Term”). 

(b) Election to Terminate. The Company may terminate this Agreement either with respect to all, or with respect to any one or more, of
the Services provided hereunder (including, without limitation, terminating the provision of Services by any member or members of the Wellspring Key Team) at any time and from time to time, for any reason or no reason, by giving written notice to
Wellspring at least thirty (30) days prior to the date of such termination. Wellspring may terminate this Agreement either with respect to all, or with respect to any one or more, of the Services provided hereunder at any time and from time to
time, for any reason or no reason, by giving written notice to the Company at least thirty (30) days prior to the date of such termination. In addition, the parties may at any time agree in writing to terminate this Agreement with respect to
some or all of the Services, effective immediately or as indicated in such writing. In the event of any termination with respect to one or more, but less than all, Services, this Agreement shall continue in full force and effect with respect to any
Services not terminated hereby. 
 (c) Payment Upon Early Termination. In the event of termination of this Agreement or any Services
hereunder, Wellspring shall be paid for all work completed through the date of termination in accordance with this Agreement, including reasonable and documented 

  
 6 

 
out-of-pocket expenses and any non-cancelable commitments incurred by Wellspring in accordance with this Agreement. Wellspring shall refund to the Company
any prepaid amounts not earned by Wellspring prior to the date of such termination, including as set forth in Section 2.2 hereof. 

(d) Survival Upon Termination. Expiration or termination of this Agreement will not relieve either party of any obligation accruing
prior to such expiration or termination. Article 1, Sections 2.2, 2.4, 2.5, 2.6(c), 2.6(d), 3.4 and 3.5, and Articles 4 and 5 will survive expiration or termination of this Agreement. 

ARTICLE 3 

REPRESENTATIONS AND WARRANTIES; DISCLAIMER; LIMITATION
OF LIABILITY. 
 3.1 Mutual Representations and Warranties. Each party represents and warrants to
the other that: (a) it has full power and authority to enter into this Agreement and to perform its obligations hereunder; (b) this Agreement is legally binding upon it, enforceable against it in accordance with its terms, and does not
conflict with any agreement, instrument or understanding, oral or written, to which it is a party or by which it may be bound, nor violate any material law or regulation of any court, governmental body or administrative or other agency having
jurisdiction over it; and (c) such party is not under any pre-existing obligation inconsistent with the provisions of this Agreement.  

3.2 Wellspring Representations and Warranties. Wellspring hereby represents and warrants to the Company that: 

(a) the Services shall be performed by qualified personnel in a good, timely, efficient and professional manner; 

(b) Wellspring shall perform the Services in compliance with all applicable laws, rules and regulations, including but not limited to
the U.S. Food, Drug and Cosmetic Act and the regulations promulgated thereunder. The parties acknowledge and agree that Wellspring does not warrant or represent that the results of the Services will be acceptable to any regulatory agency to which
they are presented nor that the Company will be able to market or otherwise exploit any Company Work Product; and 
 (c) neither
Wellspring nor any Wellspring subcontractors or personnel performing Services under this Agreement have been: (i) debarred, or proposed to be debarred under Section 306(a) or 306(b) of the United States Federal Food, Drug and Cosmetic Act,
as amended from time to time, and the rules, regulations and guidelines promulgated thereunder, or under 42 U.S.C. Section 1320-7; (ii) sanctioned by, suspended, debarred, excluded or otherwise ineligible to participate in any federal or
state health care program, including Medicare and Medicaid or in any federal procurement or non-procurement programs; or (iii) charged with or convicted of any felony or misdemeanor under 42 U.S.C. Section 1320a-7(a) or 42 U.S.C.
Section 1320a-7(b)(1)-(3), or otherwise proposed for exclusion. Wellspring will promptly inform the Company, but in no event later than four (4) Business Days, if Wellspring becomes aware that its or any of its subcontractors, or any
employee of Wellspring or any of its 

  
 7 

 
subcontractors, in each case performing any Services related to development activities or in support of the marketing authorizations, is not in compliance with any of the criteria set forth in
this Section 3.2(c) on or after the Effective Date. 
 3.3 Company Representations and Warranties. The Company hereby represents
and warrants to Wellspring that: 
 (a) to the extent this Agreement provides for the Company to provide Wellspring with any
Materials, the Company has the right to provide such Materials to Wellspring for use as contemplated by this Agreement; and 
 (b) to
the Company’s knowledge, the use of such Materials as contemplated by this Agreement will not infringe the intellectual property rights of any third party. 

3.4 Disclaimer of Warranties. EXCEPT AS EXPRESSLY SET FORTH IN THIS AGREEMENT, EACH PARTY DISCLAIMS ALL WARRANTIES, EXPRESS OR IMPLIED,
INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. WITHOUT LIMITING THE GENERALITY OF THE FOREGOING, AND EXCEPT AS EXPRESSLY SET FORTH IN THIS AGREEMENT, WELLSPRING MAKES NO REPRESENTATIONS
OR WARRANTIES AS TO THE QUALITY, SUITABILITY OR ADEQUACY OF THE SERVICES FOR ANY PURPOSE OR USE. 
 3.5 Limitation of Liability.
NEITHER PARTY SHALL BE ENTITLED TO RECOVER FROM THE OTHER PARTY ANY SPECIAL, INCIDENTAL, CONSEQUENTIAL OR PUNITIVE DAMAGES IN CONNECTION WITH THIS AGREEMENT; provided, however, that this Section 3.5 shall not apply to
any breaches of Section 2.4 or be construed to limit either party’s indemnification obligations under Article 4. 

ARTICLE 4 

INDEMNIFICATION. 

4.1 By the Company. The Company hereby agrees to save, defend, indemnify and hold harmless Wellspring, its affiliates (other than the
Company) and their respective officers, directors, employees, consultants and agents (each, a “Wellspring Party”) from and against any and all losses, damages, liabilities, expenses and costs, including reasonable legal
expense and attorneys’ fees (“Losses”), to which any Wellspring Party may become subject as a result of any claim, demand, action or other proceeding by any third party to the extent such Losses arise directly or
indirectly out of (a) the performance of the Services, (b) the development, manufacture, use, handling, storage, sale or other disposition of any product by the Company, or (c) the gross negligence or willful misconduct of any Company
Party (as defined below) or the breach by the Company of any warranty, representation, covenant or agreement made by the Company in this Agreement, except, in each case, to the extent such Losses result from the gross negligence or willful
misconduct of any Wellspring Party or the breach by Wellspring of any warranty, representation, covenant or agreement made by Wellspring in this Agreement. 

  
 8 

 4.2 By Wellspring. Wellspring hereby agrees to save, defend, indemnify and hold harmless
the Company, its affiliates and their respective officers, directors, employees, consultants and agents (each, a “Company Party”) from and against any and all Losses to which any Company Party may become subject as a result
of any claim, demand, action or other proceeding by any third party to the extent such Losses arise directly or indirectly out of the gross negligence or willful misconduct of any Wellspring Party or the breach by Wellspring of any warranty,
representation, covenant or agreement made by Wellspring in this Agreement, except, in each case, to the extent such Losses result from the gross negligence or willful misconduct of any Company Party or the breach by the Company of any warranty,
representation, covenant or agreement made by the Company in this Agreement. 
 4.3 Control of Defense. In the event a party seeks
indemnification under Section 4.1 or Section 4.2, it shall inform the other party (the “Indemnifying Party”) of a claim as soon as reasonably practicable after it receives notice of the claim, shall
permit the Indemnifying Party to assume direction and control of the defense of the claim (including the right to settle the claim solely for monetary consideration with no admission of fault), and shall cooperate as requested (at the expense of the
Indemnifying Party) in the defense of the claim.  
 4.4 Liability Insurance. Each party agrees to maintain during the Term
usual and customary liability, workers compensation and errors and omissions insurance in amounts consistent with industry standards and to provide a certificate of insurance evidencing such coverage to the other party upon request. 

ARTICLE 5 

MISCELLANEOUS 

5.1 Taxes. Wellspring will pay any and all taxes levied on account of any payments made to it under this Agreement. 

5.2 Relationship of Parties. Nothing in this Agreement shall be deemed or construed by the parties or any third party as creating the
relationship of principal and agent, partnership or joint venture between the parties, it being understood and agreed that no provision contained herein, and no act of the parties, shall be deemed to create any relationship between the parties other
than the relationship of independent contractor nor be deemed to vest any rights, interest or claims in any third parties.  
 5.3
Integration. This Agreement (including the Exhibits hereto) contains the complete, final and exclusive agreement of the parties relating to the subject matter hereof, and supersedes all prior and contemporaneous oral and written agreements or
arrangements between the parties. To the extent this Agreement conflicts with any other agreements, written or oral, between the parties, this Agreement controls. 

5.4 Modification and Amendment. This Agreement may be modified or amended only by a writing signed by both parties. 

  
 9 

 5.5 Governing Law. This Agreement shall be governed by and construed in accordance with
the laws of the State of California as applied to contracts entered into entirely in California by California residents. 
 5.6 No
Implied Licenses. No right or license is granted under this Agreement by either party to the other, either expressly or by implication, except those specifically set forth herein.  

5.7 Severability. If any provision of this Agreement should be held invalid or unenforceable, the remaining provisions shall be
unaffected and shall remain in full force and effect, to the extent consistent with the intent of the parties as evidenced by this Agreement as a whole. 

5.8 Assignment. Except as expressly provided hereunder, neither this Agreement nor any rights or obligations hereunder
may be assigned or otherwise transferred by either party without the prior written consent of the other party (which consent shall not be unreasonably withheld); provided, however, that the Company may assign this Agreement and its rights and
obligations hereunder without Wellspring’s consent in connection with the transfer or sale of all or substantially all of the Company’s business to which this Agreement relates to a third party, whether by merger, sale of stock, sale of
assets or otherwise. The rights and obligations of the parties under this Agreement shall be binding upon and inure to the benefit of the successors and permitted assigns of the parties. Any assignment not in accordance with this Agreement shall be
void. 
 5.9 Headings. Section headings are for convenience of reference only and shall not be considered in the
interpretation of this Agreement. 
 5.10 Force Majeure. In the event of a delay caused by inclement weather, fire, flood,
strike or other labor dispute, act of God, act of governmental officials or agencies, or any other cause beyond the control of the parties, the party or parties so affected shall be excused from performance hereunder for the period of time
attributable to such delay, which may extend beyond the time lost due to one or more of the causes mentioned above. In the event of any such delay, the parties may, in their sole discretion, amend this Agreement, as appropriate, by mutual written
agreement. 
 5.11 Notices. Any notices required or permitted hereunder shall be given to the appropriate party at the address
specified below or at such other address as the party shall specify in writing. 
  

			
	 If to Wellspring:
		Wellspring Biosciences LLC
			11119 N. Torrey Pines Road, Suite 125
			La Jolla, CA 92037
		
	 If to the Company:
		Kura Oncology, Inc.
			11119 N. Torrey Pines Road, Suite 125
			La Jolla, CA 92037

  
 10 

 All notices under this Agreement shall be deemed made upon receipt by the addressee as evidenced
by the applicable written receipt or, in the case of a facsimile, as evidenced by the confirmation of transmission. 
 5.12
Counterparts. This Agreement may be executed in multiple counterparts, each of which shall be deemed an original and all of which together shall constitute one and the same instrument. 

5.13 Non-Waiver. No failure or delay of one of the parties to insist upon strict performance of any of its rights or powers under this
Agreement shall operate as a waiver thereof, nor shall any other single or partial exercise of such right or power preclude any other further exercise of any rights or remedies provided by law.  

5.14 Waiver of Conflicts. Each party to this Agreement acknowledges that Cooley LLP
(“Cooley”), special counsel to Wellspring with respect to this Agreement, has in the past represented and is now representing and may in the future represent the Company in matters unrelated to the transactions
contemplated by this Agreement (the “Services Agreement”), including representation of the Company in matters of a similar nature to the Services Agreement. The applicable rules of professional conduct
require that Cooley inform the parties hereunder of this representation and obtain their consent. Wellspring and the Company hereby (a) acknowledge that they are entitled to seek independent legal advice regarding the provisions of this
paragraph and the granting of the consent provided for herein, (b) acknowledge that they have had an opportunity to ask for and have obtained information relevant to such representation, including disclosure of the reasonably foreseeable
adverse consequences of such representation, (c) acknowledge that with respect to the Services Agreement, Cooley has represented solely Wellspring and not the Company or any stockholder, director or employee of the Company and (d) give
their informed consent to Cooley’s representation as special counsel to Wellspring in connection with the Services Agreement.  

5.15 Waiver of Corporate Opportunity. In the event that one of the parties to this Agreement or any director, officer, employee or
representative of such party (the “Primary Party”) acquires knowledge of a potential transaction or other matter (including, but not limited to, any compounds or other assets or the opportunity to acquire
interests thereof) and that may be an opportunity of interest (a “Corporate Opportunity”) for the other party to this Agreement (the “Other Party”), then the Other Party
(i) renounces any expectancy that the Primary Party offer an opportunity to participate in such Corporate Opportunity to the Other Party and (ii) to the fullest extent permitted by law, waives any claim that such opportunity constituted a
Corporate Opportunity that should have been presented by the Primary Party to the Other Party or any of its affiliates. 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 

  
 11 

 IN WITNESS WHEREOF, the
parties have executed this Services Agreement effective as of the date first above written. 
  

			
	 WELLSPRING BIOSCIENCES LLC

		
	By:		 /s/ Heidi Henson

	Name:    		 Heidi Henson

	Title:		 CFO

  

			
	 KURA ONCOLOGY, INC.

		
	By:		 /s/ Troy Wilson

	Name:    		 Troy Wilson

	Title:		 President & CEO

 EXHIBIT A 

SERVICES 
 1.
Subject to the provisions of Section 2 of the Agreement, Wellspring shall use commercially reasonable efforts to provide, among others, the following Services as may be requested from time to time by the Company: 

 

	 	A.	Research and Development Services. Wellspring shall provide to the Company general research and development services to be mutually agreed by the parties (“R&D Services”).

  

	 	B.	Other. Wellspring shall provide such other Services as mutually agreed between Wellspring and the Company (“Other Services”). 

 EXHIBIT B 

SERVICES FEES 
  

	1.	In consideration for the Services provided, the Company shall pay to Wellspring the following, subject to adjustment pursuant to Section 2 below: 

 

	 	A.	The Company shall pay a fee based on FTE Costs for FTEs expended in the provision of R&D Services. For clarity, FTE Costs include the costs of all consumables except as provided in paragraph C. below.

  

	 	B.	If the Company and Wellspring agree to the provision of any Other Services, the parties will mutually agree to a reasonable fee for such Services at such time. 

 

	 	C.	In addition, the Company shall reimburse Wellspring for any reagent that is above U.S.$[...***...] and in the event that the Services include chemistry scale-up efforts that require specialized reagents or
involve scale-up costs that exceed U.S.$[...***...], the Company will pay the cost of any specialized reagents required for such scale-up. 

  

	 	D.	In the event that Wellspring subcontracts Services to a third party, the third party costs incurred by Wellspring will be passed through to Company without markup. 

 

	2.	The fees for the Services set forth in Section 1 above shall be subject to the following: 

  

	 	A.	The Service fees shall be payable in U.S. dollars (unless mutually agreed by the parties) and shall be subject to all applicable government regulations and rulings. 

 

	 	B.	Wellspring shall provide the Company with documentation which may be required by the revenue authorities to support the fact that the Services fees represent arm’s length remuneration for the benefits
derived from the Services provided to the Company in that particular year. 

  

	 	C.	If at any time the amount paid under this Agreement for the Services is subsequently adjusted by a tax administration for the purposes of calculating the income tax liability of either party, the parties agree
that the amount of the adjustment shall be payable and receivable by either party, as the case may be, within 90 days of the issue date of the tax assessment under which the adjustment arises. 

 

	3.	 All payments hereunder shall be made in cash or by offset against any indebtedness owing to the Company by Wellspring. Wellspring shall invoice
the Company at least quarterly for services provided during the previous quarter, in each case as actually incurred during such quarter in performing Services: (i) FTE Costs for FTEs for which Company is obligated to reimburse Wellspring
(ii) any agreed upon fees for Other Services as described in Section 1B above, (iii) any excess supply costs as described in 

  

					
			2		***Confidential Treatment Requested

	 	
Section 1C above, and (iv) any pass through expenses as described in Section 1D above. Wellspring shall include with each such invoice reasonably detailed information documenting
FTE Costs and out-of-pocket costs incurred during the applicable time period. The Company agrees to pay all amounts due to Wellspring arising under this Agreement promptly upon receipt of any such invoice. The parties to this Agreement agree to
discuss in good faith on a semi-annual basis during the term of this Agreement the necessity or desirability of adjusting the fees set forth in this Exhibit B. 

  

	4.	The Company understands and acknowledges that Wellspring must reasonably allocate its staff resources among all of the companies to which Wellspring provides services. Notwithstanding any other provision of this
Agreement, Wellspring may at any time, without notice or liability, change or eliminate the persons who provide the Services to the Company on behalf of Wellspring pursuant to this Agreement, provided that the Services continue to be provided to the
Company on substantially the same levels as provided prior to such change or elimination. The Company expressly acknowledges that Wellspring is engaged in the business of providing drug development services to multiple companies and providing
management, scientific, business development, financial and other operational services to those companies and that neither Wellspring nor any other company to which Wellspring provides services shall have any exclusivity or similar obligation to the
Company, including without limitation any corporate opportunity obligation or any obligation to disclose or make available to the Company any information, potential transaction or other matter of which any such Wellspring Party becomes aware
otherwise than solely in the course of performing Services under this Agreement on behalf of the Company. 

  
 3 

 EXHIBIT C 

Compliance with Laws and the FCPA 
  

	1.1.	Wellspring shall become familiar with the FCPA, its prohibitions and purposes, and shall not undertake any actions that may violate the FCPA. Accordingly, Wellspring hereby agrees that: 

 

	 	(i)	no person shall be employed by it who is an official or employee of any government or any department, agency or instrumentality thereof (including, but not limited to, any health or medical providers owned or controlled
by the government); 

  

	 	(ii)	no payment or offer to pay, or the giving or offering to give, anything of value to an official or employee of any department, agency or instrumentality thereof (including, but not limited to, any health or medical
providers owned or controlled by the government), or to any political party or any candidate for political office, shall be made with the purpose of influencing any decisions favorable to either Party or its Affiliates in contravention of the FCPA
or the laws of the country in which it is providing work; 

  

	 	(iii)	it not pay, nor offer or agree to pay, nor caused to be paid, directly or indirectly, any political contributions, fees or commissions to any governmental employee or representative (including, but not limited to, any
employee of any health or medical provider owned or controlled by the government) that could cause a violation of the FCPA; 

  

	 	(iv)	it will not, directly or indirectly, in connection with the Agreement and the business resulting therefrom, offer, pay, promise to pay, or authorize the giving of money or anything of value to any governmental official
or representative, to any political party or official thereof, or to any candidate for political office, or to any person, while knowing or being aware of the probability that all or any portion of such money or thing of value will be offered,
given, or promised, directly or indirectly, to any government official, to any political party or official thereof, or to any candidate to political office, for the purpose of: 

 

	 	a.	influencing any act or decisions of such official, political party, party official, or candidate in its official capacity, including a decision to fail to perform official functions; or 

 

	 	b.	inducing such official, political party, party official, or candidate to use influence with the government or instrumentality thereof to affect or influence any act or decision of such government or instrumentality, in
order to assist either Party in obtaining or retaining business for or with, or directing business to, any third party. 

  

	 	(v)	Wellspring will immediately notify the Company if it becomes aware of any apparent violation of the FCPA in connection with its activities hereunder. 

  
 4 

	1.2.	Wellspring shall provide the Company and its agents and representatives (collectively, “Agents”), as well as any regulatory authorities having regulatory oversight of Wellspring, with access to its facilities,
records (financial and otherwise), and supporting documentation as may be requested by any Agents in order to document or verify compliance with the provisions of this Exhibit. Wellspring acknowledges that the provisions of this Exhibit granting the
Company certain audit rights shall in no way relieve Wellspring of any of its obligations under the Agreement, nor shall such provisions require the Company to conduct any such audits. 

 

	1.3.	Wellspring shall maintain true and accurate records necessary to demonstrate compliance with this Agreement (including the requirements of this Exhibit). 

 

	1.4.	If Wellspring fails to comply with any of the provisions of this Exhibit (irrespective of the size, nature or materiality of such violation), such failure may be treated by the Company as a material breach.

  

	1.5.	Notwithstanding anything to the contrary in the Agreement, each Party may disclose its terms and conditions (including any financial terms) to any government authority that it determines in good faith has a legitimate
need for access to such information (including, but not limited to, any governmental authorities in the U.S. or those in the country where research is being provided). 

  
 5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00245-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00245-of-00352.parquet"}]]